BioCryst grants new hires stock options for 33,950 shares at $9.65 each

BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc.

BCRX

0.00
  • BioCryst granted inducement equity awards to nine new hires, totaling options for 33,950 shares, RSUs for 91,750 shares.
  • Stock options priced at $9.65 per share, matching the closing price on the July 1, 2026 grant date.
  • Awards vest in four equal annual installments starting one year from grant, subject to continued service.
  • Options carry a 10-year term.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCryst Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607020700PRIMZONEFULLFEED9755873) on July 02, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.